Physiological, mechanical, and immunologic alterations in pregnancy could potentially affect the susceptibility to and the severity of COVID-19 during pregnancy. Owing to the lack of comparable incidence data and the…
The advancement of women leaders in obstetrics and gynecology does not reflect the changes in the physician workforce seen over the last 50 years. A core value of our culture…
Objective Considering the issue of endometrial cancer, the role of social support in the experiences of Black women has not been explored. We share our process of stakeholder engagement that…
We appreciate the comments from Dr Sun regarding the challenges of calculating the risk of early pregnancy loss (EPL) in the Pregnancy Coronavirus Outcomes Registry (PRIORITY) study. PRIORITY participants were…
Objective The initial studies of COVID-19 suggested that pregnant women have more severe infection with an increased risk of preterm birth, preterm rupture of membranes, and even maternal deaths. Later…
We thank the authors for writing the letter to the editor underlining their important comments. Indeed, the study type of the INSPIRE trial was initially incorrectly presented in Table 1 in…
We read with great interest the review by Verlohren and Droge on the diagnostic value of angiogenic and antiangiogenic factors in the differential diagnosis of preeclampsia. We noted that the…
Objective The risk of severe uterine bleeding (SUB) reported in oral anticoagulant (OA) clinical trials is likely underestimated because of the low representation of women of reproductive age. In a…
Objective Home births in the United States are associated with increased patient-risk profiles, neonatal injury, and death. Recently, research was published that showed that home births in the State of…
Background 17α-hydroxyprogesterone caproate is a synthetic progestogen initially approved in the 1950s to treat gynecologic and obstetrical conditions. Despite continued concerns about safety and short-term efficacy regarding the use of…
